Institute for OneWorld Health
Latest From Institute for OneWorld Health
RXi Pharmaceuticals, a US biopharmaceutical company focused on the development and commercialisation of therapeutics based on RNAi, has appointed Dr Richard Chin, chief executive officer of the Institute for OneWorld Health, to its board of directors.
The Institute for OneWorld Health, a US non-profit pharmaceutical company developing drugs for neglected infectious diseases in the developing world, has appointed Dr Menghis Bairu to its board of directors. He is executive vice-president, head of global development and chief medical officer for Elan.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.